LEA29Y

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LEA29Y, covering 2016-09-16 to 2016-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis [Phase 1, Phase 2]